Ko DT, Khan AM, Kotrri G, Austin PC, Wijeysundera HC, Koh M, Chu A, Jackevicius CA, Lawler PR, Tu JV. Eligibility, clinical outcomes, and budget impact of PCSK9 inhibitor adoption: the CANHEART PCSK9 study. J Am Heart Assoc. 2018 Nov 6;7(21):e010007. doi: 10.1161/JAHA.118.010007
Vinceti M, Filippini T, Rothman KJ. Selenium exposure and the risk of type 2 diabetes: a systematic review and meta-analysis. Eur J Epidemiol. 2018 Sep;33(0):789-810. doi: 10.1007/s10654-018-0422-8.
Margulis AV, Hallas J, Pottegard A, Kristiansen NS, Atsma WJ, Franks B, D´Silva M, Varas-Lorenzo C, Perez-Gutthann S, Arana A. Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort study. Eur J Clin Pharmacol. 2018 Feb;74(2):193-9. doi: 10.1007/s00228-017-2359-3